Sterility concerns prompt recall of drugs from Fla. compounder

05/10/2013 | Modern Healthcare (subscription required)

The FDA warned pharmacists and doctors not to use treatments from The Compounding Shop, a specialty pharmacy in Florida, prompting it to notify customers and recall all of its sterile treatments. An inspection of the compounder raised concerns about sterility issues regarding its drugs that could cause bacterial contamination, the FDA said.

View Full Article in:

Modern Healthcare (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA